Gene amplification in a leukemic patient treated with methotrexate.

Resistance to methotrexate (MTX) has been shown in mouse, hamster, and human cell lines grown in sequentially increased MTX concentrations to be due to increased dihydrofolate reductase (DHFR) synthesis and a proportional increase in DHFR gene copy number. Leukemia cells of a patient were studied to assess change in DHFR gene copy number after MTX treatment. The patient presented with chronic myeloid leukemia which rapidly evolved into blast crisis; 90% of peripheral white cells were lymphoblasts. Treatment included intrathecal and intravenous MTX; the lymphoblasts were reduced to undetectable levels. Three months later a second blast crisis occurred; 90% of peripheral white cells were lymphoblasts. Cells from each blast crisis were obtained by leukapheresis and stored for study. Quantification of DHFR gene copy number in DNA from lymphoblasts before and after MTX treatment was done: a radiolabeled cloned cDNA constituting the mouse DHFR coding sequence was used to probe high molecular weight pretreatment and posttreatment DNA bound to nitrocellulose filters. Posttreatment DNA contained two- to three-fold more DHFR gene sequences than pretreatment DNA. Quantitative Southern blotting of EcoRI-digested pretreatment and posttreatment DNA confirmed amplification of the DHFR gene. Karyotype analysis showed no double minute chromosomes or homogeneously staining regions. This is the first study demonstrating DHFR gene amplification in leukemia cells sampled in vivo from a patient treated with MTX.

[1]  S. Beverley,et al.  Rapid spontaneous dihydrofolate reductase gene amplification shown by fluorescence-activated cell sorting. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[2]  J. Minna,et al.  Unstable methotrexate resistance in human small-cell carcinoma associated with double minute chromosomes. , 1983, The New England journal of medicine.

[3]  A. Nienhuis,et al.  Intronless human dihydrofolate reductase genes are derived from processed RNA molecules. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[4]  R T Schimke,et al.  Loss and stabilization of amplified dihydrofolate reductase genes in mouse sarcoma S-180 cell lines , 1981, Molecular and cellular biology.

[5]  D. Woodcock,et al.  Aberrant double replication of segments of chromosomal DNA following DNA synthesis inhibition by cytosine arabinoside. , 1979, Experimental cell research.

[6]  Stanley N Cohen,et al.  Phenotypic expression in E. coli of a DNA sequence coding for mouse dihydrofolate reductase , 1978, Nature.

[7]  J. Bertino,et al.  Selective multiplication of dihydrofolate reductase genes in methotrexate-resistant variants of cultured murine cells. , 1978, The Journal of biological chemistry.

[8]  E. Southern Detection of specific sequences among DNA fragments separated by gel electrophoresis. , 1975, Journal of molecular biology.

[9]  B. Chabner,et al.  ALTERED PLASMA PHARMACOKINETICS OF METHOTREXATE ADMINISTERED INTRATHECALLY , 1975, The Lancet.

[10]  R. Jackson,et al.  Studies with a mathematical model of folate metabolism. , 1973, Archives of biochemistry and biophysics.

[11]  J. Bertino,et al.  The “induction” of leukocyte and erythrocyte dihydrofolate reductase by methotrexate , 1965, Clinical pharmacology and therapeutics.

[12]  F. M. Huennekens,et al.  THE "INDUCTION" OF DIHYDROFOLIC REDUCTASE ACTIVITY IN LEUKOCYTES AND ERYTHROCYTES OF PATIENTS TREATED WITH AMETHOPTERIN. , 1963, The Journal of clinical investigation.